Lab Tested
British Dragon Testabol Testosterone 250 and 100 mg Vials
Out of stock
Injection · 5 mg · vial
British Dragon TB-500 is the synthetic acetylated fragment of thymosin beta-4, supplied as a research powder in a 5 mg vial for laboratory work on connective tissue and cell migration. No regulator has approved it for human use.
GMP-manufactured, each batch HPLC-verified with the Certificate of Analysis on file. TB-500 for sale with international shipping at GenXXLGear.
British Dragon TB-500 is a synthetic peptide: the acetylated fragment Ac-LKKTETQ of the protein thymosin beta-4, supplied as a research powder in a 5 mg vial. It is studied for connective tissue and cell migration in laboratory models rather than as a hormone, and no regulator has approved it for human use. It is most often ordered beside BPC-157 when the design covers tissue repair.
Thymosin beta-4 is a small actin-binding protein found in most cells, and TB-500 is the short active fragment of it. The research literature describes it as promoting cell migration, blood vessel formation and the organisation of the actin cytoskeleton, which is the mechanism generally used to explain the connective tissue and wound repair read-outs seen in animal models. The limits of that evidence matter: no half-life has been established for TB-500, and the sources consulted state that absence of data openly rather than filling it in. The repair side of the catalogue also includes GHK-CU for collagen work. In sport TB-500 is not a grey area: thymosin beta-4 and its derivatives are named in WADA class S2 and prohibited at all times.
Add bacteriostatic water down the wall of the vial and swirl gently instead of shaking it, because the peptide chain is fragile. A 5 mg vial with 2 ml of solvent gives 2.5 mg per ml, which is the arithmetic used in the reconstitution examples published for the neighbouring peptide lines. Keep the powder cold and dry before use, hold the dissolved solution at 2-8 C, do not freeze it, and avoid repeated freeze and thaw cycles. Human pharmacokinetics are not established, so the amounts quoted by suppliers are research references only. A separate solvent is listed as Bacteriostatic Water, and the same fragment from another line is described on the Axiolabs TB 500 page.
For laboratory research only. Consult a healthcare professional before use. Figures quoted are community protocols and research references, not a prescription.
| Trade Name | TB-500 |
| Generic Name | Thymosin beta-4 fragment (Ac-LKKTETQ) |
| Manufacturer | British Dragon |
| Dosage | 5 mg per vial |
| Package | Single vial, research powder |
| Drug Class | Synthetic peptide fragment, research peptide |
| Administration | Research use after reconstitution |
| Storage | Powder cold and dry; solution 2-8 C, do not freeze |
| Prescription Status | Research use only; not for human use |
| Verification | GMP production, third-party HPLC, COA per batch |
| Shipping | International 4-10 days |
Before you ask
It is the acetylated fragment Ac-LKKTETQ of the protein thymosin beta-4, supplied as a 5 mg research powder in a vial. Thymosin beta-4 is a small actin-binding protein present in most cells, and TB-500 is the short active piece of it. It is studied for connective tissue and cell migration in laboratory models, and no regulator has approved it for human use.
Add bacteriostatic water down the wall of the vial and swirl gently rather than shaking it, because the peptide chain is fragile. A 5 mg vial with 2 ml of solvent gives 2.5 mg per ml, which is the arithmetic used in the reconstitution examples published for the neighbouring peptide lines. Keep the powder cold and dry, hold the solution at 2-8 C, do not freeze it, and avoid repeated freeze and thaw cycles.
No. The sources consulted state that no half-life has been established for TB-500, and rather than filling that gap with a made-up number this page says so openly. Human pharmacokinetic data is not available for the fragment. The practical consequence is that any figure quoted online for clearance is a vendor estimate, not a measurement, and should be read as such.
There is no clinical dataset to draw a human side-effect profile from, and this page will not invent one. The material is sold for laboratory work and is not approved for human use, so any use outside a research setting sits outside its intended purpose. The published notes for the peptide class are limited, and the honest position is that the risks of human use are not characterised.
Yes. Thymosin beta-4 and its derivatives are named in WADA class S2, and TB-500 is given as the example, which means the substance is prohibited at all times, in and out of competition. Nothing on this page should be read as guidance on testing or as permission to use the material in sport.
The 5 mg vial is listed on this page. Availability is shown on the product page, which also takes an email address for restock notices when the item is out. Shipping details are in the product data: international delivery with discreet plain packaging, and one to two business days of handling once an order is placed.
Be the first to share your experience with British Dragon TB-500 5 mg Thymosin Beta-4 Peptide Vial
Log in to write a reviewComplete the cycle
Lab Tested
Out of stock
Out of stock
Out of stock